Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Michalski

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
European Urology|March 20, 2013
Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidityKenneth G Nepple, Andrew J Stephenson, Dorina Kallogjeri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2021
Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistencyStephen F Kry, Jessica Lye, Catharine H Clark, et al.
Journal of the American College of Radiology : JACR|May 26, 2023
ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update, Dhakshinamoorthy Ganeshan, Gaurav Khatri, et al.
American Journal of Clinical Oncology|December 22, 2023
ACR-ACNM-ARS-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With RadiopharmaceuticalsPaul E Wallner, Don C Yoo, Jeremie Calais, et al.
Journal of Neuro-Oncology|November 30, 2005
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology groupMurali M Chintagumpala, Henry S Friedman, Clinton F Stewart, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408Daniel J Krauss, Chen Hu, Jean-Paul Bahary, et al.
Frontiers in Oncology|February 13, 2023
Quality improvements in radiation oncology clinical trialsKoren Smith, Kenneth Ulin, Michael Knopp, et al.
Practical Radiation Oncology|December 15, 2022
Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert PanelAbhishek A Solanki, Lindsay L Puckett, Ksenija Kujundzic, et al.
JAMA Oncology|November 26, 2015
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical TrialBenjamin Movsas, Chen Hu, Jeffrey Sloan, et al.
JAMA Oncology|July 22, 2021
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology GroupSarah E S Leary, Roger J Packer, Yimei Li, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
European Urology|March 20, 2013
Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidityKenneth G Nepple, Andrew J Stephenson, Dorina Kallogjeri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2021
Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistencyStephen F Kry, Jessica Lye, Catharine H Clark, et al.
Journal of the American College of Radiology : JACR|May 26, 2023
ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update, Dhakshinamoorthy Ganeshan, Gaurav Khatri, et al.
American Journal of Clinical Oncology|December 22, 2023
ACR-ACNM-ARS-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With RadiopharmaceuticalsPaul E Wallner, Don C Yoo, Jeremie Calais, et al.
Journal of Neuro-Oncology|November 30, 2005
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology groupMurali M Chintagumpala, Henry S Friedman, Clinton F Stewart, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408Daniel J Krauss, Chen Hu, Jean-Paul Bahary, et al.
Frontiers in Oncology|February 13, 2023
Quality improvements in radiation oncology clinical trialsKoren Smith, Kenneth Ulin, Michael Knopp, et al.
Practical Radiation Oncology|December 15, 2022
Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert PanelAbhishek A Solanki, Lindsay L Puckett, Ksenija Kujundzic, et al.
JAMA Oncology|November 26, 2015
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical TrialBenjamin Movsas, Chen Hu, Jeffrey Sloan, et al.
JAMA Oncology|July 22, 2021
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology GroupSarah E S Leary, Roger J Packer, Yimei Li, et al.
Pageof 11